S.H.E (Self. Healing. Empowerment.) is Beautiful

The “S.H.E (Self. Healing. Empowerment.) is Beautiful” event held on Wednesday, December 14, 2016 was a huge success. pic1Over 125 HIV clinical and service providers and their clients attended the event.   This one-day training was coordinated by the Los Angeles Women PrEP Network, which includes community representatives from the Los Angeles Women’s Collaborative, LA County HIV Drug & Alcohol Task Force, APLA Health, UCLA Center for AIDS Research (CFAR), One Woman Can, and UCLA/Los Angeles Family AIDS Network (LAFAN).

pic3The event included presentations from Dr. Nina Harawa, Associate Professor from UCLA and Charles R. Drew University, Dr. Gifty-Maria Jane Ntim, Medical Director at APLA Health and Wellness, Dr. LaShonda Spencer, Assistant Professor from the University of Southern California, Dr. Hilda Sandoval, Mental Health Manager at AltaMed, Roxanne Lewis from Universal Condom Work Group Los Angeles, and many others. There was a consumer workshop on HIV and PrEP (Pre-Exposure Prophylaxis) facilitated by Susan Alvarado, MPH from APLA Health and Wellness, in addition to a workshop on HIV prevention strategies led by Traci Bivens-Davis. A major highlight of the event was the community panel discussion, which included women who are currently using PrEP. They shared their real-life stories behind why they decided to use PrEP and their experiences using this novel biomedical intervention.

pic4The event was sponsored by the County of Los Angeles, Division on HIV and STD Programs. Additional funding was provided by UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS), and Walgreens.

Congratulations to the LA Los Angeles Women PrEP Network for hosting a wonderful event and to everyone who attended!

Methods Seminar – Antonio Pedro Ramos, PhD on Measuring Inequality in Early-Life Mortality Within and Between-Groups Over Time: A Bayesian Approach with Application to India

Antonio Pedro Ramos. PhD
Postdoctoral Scholar
Department of Biostatistics,
Fielding School of Public Health, UCLA
California Center for Population Research, UCLA

Most studies on early-life mortality compare mortality rates between large groups of births, such as across countries, income groups, ethnicities, or times. These studies do not measure within-group disparities. The few studies that have looked at mortality across the entire population of births, however, have used tools from the income inequality literature. Using a large data set from India, we estimate mortality risk for over 400,000 births using a Bayesian hierarchical model. We show that while measures based on the income inequality literature, such as Gini indices, are not appropriate for mortality risk, most of the variance in mortality risk occur within-groups of births. We developed a novel approach to investigate inequality in mortality risk. Our approach uncovers several important patterns in the dynamics of inequality in infant mortality and has broader applicability to other health outcomes.

The CHIPTS’ Methods Core hosts a monthly seminar series, which are one-hour workshops on research and statistical methods.  The seminars are open to HIV researchers, faculty, students, and community. To see previous seminars, check out the Methods Seminar tag or you can find seminar videos on our Youtube Channel! This series is hosted by the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and made possible by funds from the National Institute of Mental Health (MH058107).

NIDA is now accepting applications for the Director’s Travel Awards

NIDA is now accepting applications for the Director’s Travel Awards to attend the 2017 College on Problems of Drug Dependence (CPDD) annual meeting in Montreal, Canada. We anticipate a limited number of awards in the amount of $1,000.00 each. Please note that the deadline for application is January 9, 2017. This is a fantastic opportunity to partially offset travel cost to the CPDD meeting.

This award is open to NRSA trainees, NRSA fellows, and Diversity Supplement recipients, and is contingent on attending the Grant-Writing and Career Workshop at the CPDD meeting. The workshop is for junior and early career investigators, and is designed to convey information and skills, such as grantsmanship, that would be helpful in the early stages of a research career.  Selection for the travel award will automatically enroll the applicant in this workshop. For those interested in the workshop alone (i.e., not applying for the travel award), a pre-registration form will be posted on the CPDD website at a later date.

The Director’s Travel Award application is available on the CPDD website:

(http://cpdd.org/about-us/travel-awards/travel-award-descriptions/).

UCLA CFAR / AIDS Institute Grand Rounds: Carl Dieffenbach, PhD – "HIV Research: Creating Synergies to End AIDS"

This monthly lecture series, which is offered by the UCLA CFAR / AIDS Institute, consists of hour-long lunchtime lectures, delivered by invited guests or distinguished members of the Institute faculty, on a broad range of subjects. The aims of the program are to highlight important developments in AIDS-related research, encourage collaborations between UCLA investigators and invited speakers, interest young investigators in AIDS research, and provide information about new findings and new funding opportunities.

Carl Dieffenbach, PhD

Director, Division of AIDS, National Institute of Allergy and Infectious Diseases National Institutes of Health

“HIV Research: Creating Synergies to End AIDS”

Hosted by the Clinical Therapeutics and Biomedical Prevention Program Section

 

[Download not found]

 

World AIDS Day 2016: What’s it to YOU?

Tremendous medical advances in treatment and prevention for HIV exist right now that, if implemented, could stop even one new case of HIV. These interventions are ALREADY having an effect – including a 19% reduction in new diagnoses in the U.S. in 2015. Yet infections still increase in young African American men who have sex with men (MSM) and Latino MSM. So the greatest challenge to Americans who want to stop HIV infections is whether there we have the will to allocate the resources needed to implement these advances. On a daily basis, the question of “will” is answered by the local, state and national professionals who determine health policy and allocate (or restrict) resources that address HIV treatment and prevention in our communities.

Yet all politics are local. So while these decisions are made by our health professionals, each of us shares in the responsibility for their decisions. Our own “will” (or won’t) is measured by our decision to get involved (or not) on making good on our own commitment to stop HIV transmission right here, right now, in Los Angeles.

The facts are unequivocal: People living with HIV who maintain viral suppression by adhering to anti-retroviral medications are not going to transmit. People living with high risk for HIV infection (for example someone in a relationship whose partner is HIV-positive (but untreated or newly on treatment) or who has unprotected sex with HIV-positive or unknown serostatus partners) can eliminate risks for infection by using biomedical (daily oral Pre-Exposure Prophylaxis (PrEP) and behavioral prevention methods (regular HIV and STD testing and condom use).

Yet while we have the treatment and prevention tools, we are seeing no measurable reduction in HIV infections among the Americans who face highest risks: African American and Latino MSM. The situation is even more dire among the youth in these groups.

So? What’s it to YOU?

One of the easiest things you can do is to stay involved in the fight to make sure that each resident of Los Angeles has consistent access to healthcare. It is not mysterious that those bearing the brunt of new infections are people who have problems with access to healthcare. Those living with HIV or who are at risk and have inadequate access to healthcare also have high risk for untreated other chronic diseases such as diabetes, heart disease, and addiction—each of which bring their own medical consequences.

So this World AIDS Day, you don’t have to be a scientist or an advocate or a philanthropist to make a difference. Each of us bears the responsibility to demand that our systems provide consistent access to healthcare to each one of us and to make sure that as part of that, each of us can access biomedical treatment and prevention for HIV. We all need to hold ourselves, our colleagues, our healthcare providers, our public officials, and our politicians accountable for playing their part in working toward eliminating new HIV infections.   There is still much work to do.

Methods Seminar – Matt Beymer, PhD on Is PrEP for Me? Utilizing Longitudinal HIV Testing and Diagnosis Data to Inform the Creation of an Algorithm for Pre-Exposure Prophylaxis Use

Matt Beymer, Ph.D.
Postdoctoral Scholar, UCLA David Geffen School of Medicine

 

Pre-exposure prophylaxis (PrEP) is a once-a-day pill that can greatly reduce the chances of contracting HIV among HIV-negative individuals. Although PrEP is recommended for certain groups of gay and bisexual men, many men are still unsure if PrEP is right for them. This talk will detail the methods used to create a prospective HIV Risk Algorithm which provides targeted PrEP recommendations for gay and bisexual men in Los Angeles. The talk will conclude with a presentation of the interactive website developed from this study and a look forward towards enhancing PrEP uptake among the groups most heavily affected by HIV.

The CHIPTS’ Methods Core hosts a monthly seminar series, which are one-hour workshops on research and statistical methods.  The seminars are open to HIV researchers, faculty, students, and community. To see previous seminars, check out the Methods Seminar tag or you can find seminar videos on our Youtube Channel! This series is hosted by the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and made possible by funds from the National Institute of Mental Health (MH058107).

1 2 3 8